wellrank.ai
LaserCap logo

LaserCap

First cited by AI Jun 13, 2026
lasercap.com

Surfaced organically in AI answers about hair loss treatment. Not yet profiled.

AI Visibility

Visibility trend

Hair loss treatment, daily share of AI answers mentioning LaserCap, through Jun 13, 2026.

8.3%

Avg position when mentioned: 4.0

By engine

Where LaserCap is strong, and where it is invisible.

  • ChatGPT
    33.3%

Mention sentiment

Tone of AI mentions across all tracked answers.

  • 1 positive mentions
  • 0 neutral
  • 0 mixed or cautious

Recent AI answers mentioning LaserCap

ChatGPTJun 13, 2026, 11:03 UTC
What is the best hair loss treatment for women?

Short answer: there’s no single “best” treatment for all women — the right option depends on the cause. For the most common problem (female pattern hair loss / androgenetic alopecia), first‑line, evidence‑based choices are topical minoxidil and anti‑androgen therapy; other effective options include PRP, low‑level laser therapy, and (for select patients) hair transplant. For alopecia areata, the newly approved JAK inhibitor baricitinib (Olumiant) and steroid injections are options. Practical, named recommendations and why they’re used Rogaine (minoxidil) Women’s 5% Foam — FDA‑approved for female pattern hair loss; improves hair density and is the usual first‑line topical treatment. It’s easy to use at home; expect 3–6 months to see results. Spironolactone (brand: Aldactone) — an oral anti‑androgen commonly prescribed off‑label for women with androgenetic hair loss or PCOS‑related hair thinning. Often effective for slowing loss and regrowing hair in androgen‑driven cases. Requires medical supervision (blood pressure, potassium, pregnancy avoidance). Low‑dose oral minoxidil (off‑label; prescribed by dermatologists) — many dermatologists now use 0.25–2.5 mg nightly when topical minoxidil isn’t sufficient. Can be very effective but needs monitoring (blood pressure, side effects). Platelet‑Rich Plasma (PRP) at a board‑certified dermatologist’s office — an in‑office procedure with growing evidence for improving hair thickness; often used as an adjunct to medical therapy. Quality varies by clinic, so choose a reputable, experienced provider. Low‑level laser devices (brands: HairMax, LaserCap) — home devices with clinical studies showing modest improvement in hair density; good adjunct or for patients wanting a non‑drug option. Hair transplant (FUE) at established clinics (examples: Bernstein Medical, reputable local hair transplant centers) — effective for stable, advanced pattern hair loss when medical treatments are insufficient. Requires skilled surgeon and realistic expectations. For alopecia areata: Olumiant (baricitinib) — FDA‑approved for severe alopecia areata in adults; intralesional corticosteroid injections are also standard and often effective for patchy disease. Supplements: Nutrafol and Viviscal — some women report benefit; evidence is mixed but they can help when nutritional deficiencies are contributing. Always check iron, vitamin D, B12 first. Important safety and diagnostic notes Get a proper diagnosis first — causes include androgenetic alopecia, telogen effluvium (stress, meds, childbirth), alopecia areata, thyroid disease, iron deficiency, and more. Tests commonly ordered: TSH, ferritin, CBC, and hormone testing if signs of PCOS. Avoid teratogenic medications (finasteride/Propecia is contraindicated in women who may become pregnant). Spironolactone and some oral meds require reliable contraception. Work with a board‑certified dermatologist or hair specialist (trichologist supervised by a dermatologist) for prescriptions, injections, PRP, or transplants. Suggested next steps Book an appointment with a dermatologist experienced in hair loss (in person or via reputable telederm). Get basic labs (TSH, ferritin, CBC; others as suggested). If you have female pattern hair loss, start topical minoxidil (Rogaine Women 5% Foam) and discuss spironolactone or low‑dose oral minoxidil if needed. Consider adjunct PRP or a laser device (HairMax/LaserCap) if you want non‑surgical enhancement. For rapid or patchy loss, ask about alopecia areata management (steroid injections, and for severe cases, Olumiant). If you tell me a bit about your symptoms (pattern of loss, how long, any recent stress/illness, age, pregnancy plans), I can suggest the most likely next step and what tests to ask your doctor for.

Mentioned in position 4 of 8

Read full answer with sources →

Public AI visibility history

Daily rank of LaserCap on our buyer intent questions, per category. A dash means the engines did not cite LaserCap at all that day. This record is permanent.

CategoryJun 11Jun 12Jun 13
Hair loss treatment#27

TL;DR

LaserCap is a consumer and clinical low-level laser therapy (LLLT) device company focused on at-home hair loss treatment. It sells wearable laser caps designed to stimulate hair follicles and slow or reverse androgenetic alopecia. In WellRank's latest AI-answer index, LaserCap ranks tenth in the hair loss treatment category with 8% visibility, and the single AI mention captured in the corpus is positive in tone.

Company Overview

LaserCap, operating at lasercap.com, develops and markets FDA-cleared wearable low-level laser therapy devices intended to treat hair thinning and loss. The company sells primarily through a network of physician distributors as well as direct-to-consumer channels, positioning its products at the intersection of clinical-grade technology and home convenience. Founding details and headquarters are not publicly disclosed in widely available sources.

Product Features

  • Wearable laser cap form factor designed to fit discreetly under a hat or cap during use
  • FDA-cleared low-level laser therapy (LLLT) technology targeting hair follicle stimulation
  • Rechargeable, cordless design intended for hands-free at-home treatment sessions
  • Multiple diode-count configurations offered across product tiers
  • Physician-distributed models alongside direct consumer purchase options

Target Market

LaserCap primarily serves adults experiencing androgenetic alopecia, commonly known as male- or female-pattern hair loss. Its products are marketed to both individual consumers seeking at-home solutions and to physicians who recommend or resell the devices as part of a broader hair restoration plan. Distribution appears concentrated in North America, though broader availability is not publicly detailed.

Buyer Personas

  • A middle-aged man in early-to-mid stages of male-pattern baldness who wants a clinically credible, non-invasive option he can use at home without frequent clinic visits.
  • A woman experiencing diffuse thinning who has already tried topical treatments and is looking for a device-based step up in her hair care routine.
  • A hair restoration physician or dermatologist seeking an FDA-cleared adjunct therapy to recommend or offer alongside other treatments in their practice.
  • A health-conscious consumer who researches medical-grade wellness devices and prioritizes regulatory clearance before purchasing any personal health technology.

Funding & Performance

Funding stage, investor details, and company valuation are not publicly disclosed. It is not known to be a publicly traded company.

Recent Developments

LaserCap has generally continued to expand its diode configurations and refine device ergonomics over successive product generations, a direction consistent with broader LLLT device market trends. The company has maintained its physician-distribution channel while also making devices more accessible through direct consumer sales. No specific recent launch details with confirmed dates are widely available in public sources.

Competitive Landscape

According to WellRank co-mention data, AI engines most frequently discuss LaserCap alongside HairMax, Rogaine, Nutrafol, Viviscal, Bernstein Medical, Olumiant, and Aldactone. HairMax represents the most direct product-category competitor, as it also sells FDA-cleared LLLT laser devices for home use. Rogaine and Nutrafol compete in the broader hair loss treatment space through topical and supplement approaches respectively, while Bernstein Medical represents the clinical hair transplant segment. LaserCap's LLLT positioning differentiates it from purely pharmaceutical or supplement options.

LaserCap vs the brands AI recommends alongside it

The real competitive set in Hair loss treatment: brands the engines name in the same answers, ranked on the latest day.

BrandRankAI visibility
LaserCap logo
LaserCapThis brand
#27
8.3%
Aldactone logo
Aldactone

1 shared answers

#21
8.3%
Bernstein Medical logo
Bernstein Medical

1 shared answers

#28
8.3%
HairMax logo
HairMax

1 shared answers

#18
8.3%
Nutrafol logo
Nutrafol

1 shared answers

#6
25.0%

Email me when overtakes LaserCap

One email the day the ranks flip. Nothing else.

User Sentiment

WellRank's AI-answer corpus records one mention of LaserCap, and that mention is positive in tone, with no neutral or mixed signals captured in the current dataset. Broader consumer sentiment online tends to focus on the convenience of the wearable format and the reassurance of FDA clearance, though individual results for LLLT devices are widely noted to vary. The limited mention volume in AI answers suggests the brand has room to grow its AI visibility beyond its current 8% share in the hair loss treatment category.

Pricing

Pricing is not published in a standardized way across all channels. LaserCap devices are generally understood to be positioned as premium LLLT products, with costs varying depending on the diode configuration chosen and whether the purchase is made directly or through a physician distributor. Exact current figures are not reliably confirmed in widely available public sources.

Sources cited around LaserCap

The sites engines cite in answers mentioning this brand. Win these, win the answer.

    Track LaserCap weekly

    One email a week: rank moves, new competitors, and the answers that changed. No noise.

    Work at LaserCap? Get your AI Visibility Audit.

    See every buyer intent question your customers ask AI, which ones you are losing, who wins them instead, and the exact sources driving those answers. You will finally understand your buyer intent and what Propel would do to win it.